In the BioHarmony Drug Report Database

"Preview" Icon

Esmolol

Brevibloc, Esmolol (esmolol) is a small molecule pharmaceutical. Esmolol was first approved as Brevibloc on 1988-08-15. It is used to treat angina pectoris, heart failure, hypertension, myocardial infarction, and supraventricular tachycardia amongst others in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. Brevibloc’s patents are valid until 2033-03-15 (FDA).

 

Trade Name

 

Brevibloc, Esmolol
 

Common Name

 

esmolol
 

ChEMBL ID

 

CHEMBL768
 

Indication

 

angina pectoris, heart failure, hypertension, myocardial infarction, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia
 

Drug Class

 

Beta-blockers (propranolol type)

Image (chem structure or protein)

Esmolol structure rendering